Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder
Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder buy - large image1
Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder buy - image1
Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder buy - image2
Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder buy - image3

Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder

2101 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Laboratory Grade

Content:

99%

Port:

shenzhen

Packaging:

10mg*10vials

Price valid (until):

2026-06-22

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Polypeptide Products

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      contact us  


    Name:Alex

    Telegram:+852 5603 8853

    Whatsapp:+852 5603 8853

    Email Address:xu.wenxuan@boruimei.com

    Items Specifications
    Product Name:   Tirzepatide
       CAS: 2023788-19-2
       Purity 99%
       Shelf life: 24 months
       Specification: 10mg/vial 10vials /box
       Appearance:

    Lyophilized powder

    Product Features

    • High Purity:The purity is ≥99% (HPLC), single impurity ≤0.1%, complies with research quality standards, COA certificate available to guarantee stable and reliable quality.
    • Stable Performance: Adopts lyophilized powder form with great stability, easy storage and transportation, effectively retains original biological activity.
    • Clear Mechanism:Triple agonist targeting GLP-1, GIP and GCGR receptors, widely applied in weight management and blood glucose regulation related research.

    Shop Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder-Detailed Image 1

    Product Features

    • High Purity:The purity is ≥99% (HPLC), single impurity ≤0.1%, complies with research quality standards, COA certificate available to guarantee stable and reliable quality.
    • Stable Performance:Adopts lyophilized powder form with great stability, easy storage and transportation, effectively retains original biological activity.
    • Clear Mechanism:Triple agonist targeting GLP-1, GIP and GCGR receptors, widely applied in weight management and blood glucose regulation related research.

    Shop Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder-Detailed Image 2

    • 1.High quality products with competitive pricing.
    • 2.Free samples available for your evaluation and testing.
    • 3.Fast, reliable delivery via reputable shipping lines.
    • 4.Trial orders are welcome for quality verification after sample approval.
    • 5.Proactive updates and full transparency at every stage of your order.
    • 6.Custom packaging solutions tailored to meet your specific requirements.

    Shop Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder-Detailed Image 3


      Our factory  


    Shop Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder-Detailed Image 4

    Shop Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder-Detailed Image 5


      How to order  


    Shop Tirzepatide | US Warehouse | GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder-Detailed Image 6


      Delivery time  


    • USA: 7-12days (tax included)

    • Europe: 7–12 days (tax included)

    • Australia: 7–12 days (tax included)

    • Canada: 7–12 days (tax included)

    • Asia and Southeast Asia: 5–10 days (tax included)

    • Free redelivery is available if the parcel fails to arrive on time.

    FAQ

    1.Can we get your free samples?

    Yes, can. Our free sample can be provided for customers test. But the freight for express is obuyer's account.

    2.Can we do printing or label on the bottles?

    Yes, can. We can offer various printing ways,such, screen printing, hot stamping, label printing.

    3.What is the normal lead time?

    For stock products, within 24-48 hours after we receive your payment. For smaller customize color bottles, we will ship out within 3-5 days.

    4.What is your shipping terms?

    Faster ways: FEDEX, DHL, UPS, TNT, etc by sea or by air economy

    5.How does your factory do regarding quality control?

    We do test for 3 times before packing.

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Polypeptide Products

    Location:

    No. 917, 9th Floor, Unit 1, Building 19, Shengshi Huayuan Business Center, Shunhua Road Sub-district, High-tech Zone, Jinan City, Shandong Province

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    5-10

    Year of Establishment:

    2026

  • Inquiry History
    2101 Inquiries
    Country Product Purchase Quantity Date Posted
    Brazil

    Tirzepatide

    100 G Oct 28, 2026
    Belgium

    Tirzepatide

    10 MG Oct 28, 2026
    United States

    tirzepatide

    100 MG Oct 28, 2026
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.